Guska
PrivateLast Round
Seed
Feb 28, 2024
Total Funding Raised
$750,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Guska operates in Healthcare & Life Sciences and is based in Montevideo. Its latest recorded funding round was a Seed round in February 2024.
Guska is a biotechnology company developing oncolytic virus-based cancer therapies using AI and synthetic biology to engineer RNA viruses that selectively destroy tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guska Comparables
Compare Guska with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IconOVir | 82% | |
| U.P. Oncolytics | 78% | |
| ImmVirx | 78% |
For institutional investors. Book with your work email.
Guska Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Guska Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ficus Capital | Seed |
| LAB+ Company Builder | Seed |
| Institut Pasteur de Montevideo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 229% MoM, reaching 1.5K.
- Jul 26, 2026
Monthly visitors increased 1129% MoM, from 38 to 467.
For institutional investors. Book with your work email.
Guska Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guska's valuation, stock price, and market status.
Is Guska a public or private company?
Guska is a private company.
What is the current stock price of Guska?
Guska is a private company, so its shares have no public market price. Caplight tracks Guska's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guska worth (valuation)?
Valuation information for Guska is not publicly available.
Can I buy Guska stock?
Guska shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guska's last funding round?
Guska's most recent funding round was Seed on February 28, 2024.
Who are the main investors in Guska?
Key investors in Guska include LAB+ Company Builder.
Will Guska IPO soon?
No public IPO plans have been announced for Guska.
How can I track Guska secondary market activity?
Caplight tracks bids, offers, and trades in Guska's shares on secondary markets.